Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer

Journal of Nutritional Biochemistry

Volumn 24, Issue 1, 2013, Pages 39-48

  Llaverias, Gemma ^a,b   Escolà Gil, Joan Carles ^a,b   Lerma, Enrique ^a,c   Julve, Josep ^a,b   Pons, Cristina ^c   Cabré, Anna ^b,d   Cofán, Montserrat ^e,f   Ros, Emilio ^e,f   Sánchez Quesada, José Luis ^a   Blanco Vaca, Francisco ^a,b,c,g  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Breast cancer; Cholesterol; Lipoprotein; MMTV PyMT mice; Oxidation; Phytosterols

Indexed keywords

CAMPESTEROL; LIPOPROTEIN; PHYTOSTEROL; SITOSTEROL; STIGMASTEROL; VIRUS MIDDLE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN DAMAGE; BREAST CANCER; BREAST HYPERPLASIA; CANCER PREVENTION; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INHIBITION; FEMALE; HISTOPATHOLOGY; INFLAMMATION; LIPID DIET; LIPID PEROXIDATION; MAMMARY GLAND; MOUSE; NONHUMAN; POLYOMA VIRUS; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VOLUME; VIRUS STRAIN;

ANIMALS; ANTIGENS, VIRAL, TUMOR; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FEMALE; LIPOPROTEINS; LIPOPROTEINS, HDL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NF-KAPPA B; OXIDATION-REDUCTION; PHYTOSTEROLS;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS; POLYOMAVIRUS;

EID: 84870407175     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.01.007     Document Type: Article

References (52)

1. Calpe-Berdiel L., Escola-Gil J.C., Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis 2009, 203:18-31.
2. Miettinen T.A., Puska P., Gylling H., Vanhanen H., Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995, 333:1308-1312.
3. Ronco A., De Stefani E., Boffetta P., Deneo-Pellegrini H., Mendilaharsu M., Leborgne F. Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer 1999, 35:111-119.
4. Berges R.R., Windeler J., Trampisch H.J., Senge T. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet 1995, 345:1529-1532.
5. Shimizu H., Ross R.K., Bernstein L., Yatani R., Henderson B.E., Mack T.M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991, 63:963-966.
6. Bradford P.G., Awad A.B. Phytosterols as anticancer compounds. Mol Nutr Food Res 2007, 51:161-170.
7. Woyengo T.A., Ramprasath V.R., Jones P.J. Anticancer effects of phytosterols. Eur J Clin Nutr 2009, 63:813-820.
8. Bradford P.G., Awad A.B. Modulation of signal transduction in cancer cells by phytosterols. Biofactors 2010, 36:241-247.
9. Hirsch H.A., Iliopoulos D., Joshi A., Zhang Y., Jaeger S.A., Bulyk M., et al. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010, 17:348-361.
10. Delimaris I., Faviou E., Antonakos G., Stathopoulou E., Zachari A., Dionyssiou-Asteriou A. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 2007, 40:1129-1134.
11. Scoles D.R., Xu X., Wang H., Tran H., Taylor-Harding B., Li A., et al. Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein. Gynecol Oncol 2010, 116:109-116.
12. Awad A.B., Downie A., Fink C.S., Kim U. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res 2000, 20:821-824.
13. Ju Y.H., Clausen L.M., Allred K.F., Almada A.L., Helferich W.G. Beta-sitosterol, beta-sitosterol glucoside, and a mixture of beta-sitosterol and beta-sitosterol glucoside modulate the growth of estrogen-responsive breast cancer cells in vitro and in ovariectomized athymic mice. J Nutr 2004, 134:1145-1151.
14. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961.
15. Maglione J.E., Moghanaki D., Young L.J., Manner C.K., Ellies L.G., Joseph S.O., et al. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001, 61:8298-8305.
16. Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003, 163:2113-2126.
17. Qiu T.H., Chandramouli G.V., Hunter K.W., Alkharouf N.W., Green J.E., Liu E.T. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res 2004, 64:5973-5981.
18. Llaverias G., Danilo C., Mercier I., Daumer K., Capozza F., Williams T.M., et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol 2011, 178:402-412.
19. Cardiff R.D., Anver M.R., Gusterson B.A., Hennighausen L., Jensen R.A., Merino M.J., et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988.
20. Heinemann T., Axtmann G., von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993, 23:827-831.
21. Ribas V., Sanchez-Quesada J.L., Anton R., Camacho M., Julve J., Escola-Gil J.C., et al. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ Res 2004, 95:789-797.
22. Brunelli R., Mei G., Krasnowska E.K., Pierucci F., Zichella L., Ursini F., et al. Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation. Biochemistry 2000, 39:13897-13903.
23. Parasassi T., De Stasio G., d'Ubaldo A., Gratton E. Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence. Biophys J 1990, 57:1179-1186.
24. Quesada A.R., Munoz-Chapuli R., Medina M.A. Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 2006, 26:483-530.
25. Tribble D.L. Lipoprotein oxidation in dyslipidemia: insights into general mechanisms affecting lipoprotein oxidative behavior. Curr Opin Lipidol 1995, 6:196-208.
26. Fuhrman B., Plat D., Herzog Y., Aviram M. Consumption of a novel dietary formula of plant sterol esters of canola oil fatty acids, in a canola oil matrix containing 1,3-diacylglycerol, reduces oxidative stress in atherosclerotic apolipoprotein E-deficient mice. J Agric Food Chem 2007, 55:2028-2033.
27. Loizou S., Lekakis I., Chrousos G.P., Moutsatsou P. Beta-sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res 2010, 54:551-558.
28. Sharpless N.E., Depinho R.A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006, 5:741-754.
29. Shenouda N.S., Sakla M.S., Newton L.G., Besch-Williford C., Greenberg N.M., MacDonald R.S., et al. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine 2007, 31:72-81.
30. Muti P., Awad A.B., Schunemann H., Fink C.S., Hovey K., Freudenheim J.L., et al. A plant food-based diet modifies the serum beta-sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr 2003, 133:4252-4255.
31. Solomon K.R., Pelton K., Boucher K., Joo J., Tully C., Zurakowski D., et al. Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol 2009, 174:1017-1026.
32. Zhuang L., Kim J., Adam R.M., Solomon K.R., Freeman M.R. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005, 115:959-968.
33. Llaverias G., Danilo C., Wang Y., Witkiewicz A.K., Daumer K., Lisanti M.P., et al. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 2010, 177:3180-3191.
34. Nomura D.K., Long J.Z., Niessen S., Hoover H.S., Ng S.W., Cravatt B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 2010, 140:49-61.
35. Li Y.C., Park M.J., Ye S.K., Kim C.W., Kim Y.N. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 2006, 168:1107-1118. quiz 1404-1105.
36. Hac-Wydro K., Wydro P., Jagoda A., Kapusta J. The study on the interaction between phytosterols and phospholipids in model membranes. Chem Phys Lipids 2007, 150:22-34.
37. Awad A.B., Chinnam M., Fink C.S., Bradford P.G. Beta-sitosterol activates Fas signaling in human breast cancer cells. Phytomedicine 2007, 14:747-754.
38. Kaneko E., Matsuda M., Yamada Y., Tachibana Y., Shimomura I., Makishima M. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem 2003, 278:36091-36098.
39. Plat J., Nichols J.A., Mensink R.P. Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res 2005, 46:2468-2476.
40. Chuu C.P., Kokontis J.M., Hiipakka R.A., Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer. J Biomed Sci 2007, 14:543-553.
41. Liang M., Zhang P., Fu J. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett 2007, 258:31-37.
42. Shih D.M., Gu L., Hama S., Xia Y.R., Navab M., Fogelman A.M., et al. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest 1996, 97:1630-1639.
43. Vivancos M., Moreno J.J. Beta-sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages. Free Radic Biol Med 2005, 39:91-97.
44. Awad A.B., Toczek J., Fink C.S. Phytosterols decrease prostaglandin release in cultured P388D1/MAB macrophages. Prostaglandins Leukot Essent Fatty Acids 2004, 70:511-520.
45. Awad A.B., Burr A.T., Fink C.S. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fatty Acids 2005, 72:219-226.
46. Ferretti G., Bacchetti T., Masciangelo S., Bicchiega V. Effect of phytosterols on copper lipid peroxidation of human low-density lipoproteins. Nutrition 2010, 26:296-304.
47. Homma Y., Ikeda I., Ishikawa T., Tateno M., Sugano M., Nakamura H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial. Nutrition 2003, 19:369-374.
48. Mannarino E., Pirro M., Cortese C., Lupattelli G., Siepi D., Mezzetti A., et al. Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. Nutr Metab Cardiovasc Dis 2009, 19:84-90.
49. Liu M., Sakamaki T., Casimiro M.C., Willmarth N.E., Quong A.A., Ju X., et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res 2010, 70:10464-10473.
50. Acharya A., Das I., Chandhok D., Saha T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev 2010, 3:23-34.
51. Su F., Kozak K.R., Imaizumi S., Gao F., Amneus M.W., Grijalva V., et al. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A 2010, 107:19997-20002.
52. Jafri H., Alsheikh-Ali A.A., Karas R.H. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 2010, 55:2846-2854.